解码抗性基因多态:对肺癌风险的影响和基化疗的临床结果
Weijing Gong1,2, Dandan Huang3, Tao Zhou1,2
1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Biomedicines
|February 26, 2025
概括
电阻素 (RETN) 表达与肺癌转移和生存相关. 在接受基化疗的患者中,RETN rs1862513多态可能预测胃肠道毒性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 抵抗蛋白 (RETN) 是一种炎症性细胞因子,在癌症进展中起作用,并将炎症与瘤发生联系起来.
- 以前的研究表明,抵抗素参与致癌和药物反应.
- 这项研究调查了与肺癌风险和结果相关的抵抗素表达和多态性.
研究的目的:
- 检查抵抗素表达和遗传多态性与肺癌风险之间的关联.
- 评估抗素对临床结果的影响,包括生存率,化疗反应和毒性.
- 探索抵抗素作为肺癌中的潜在生物标志物.
主要方法:
- 在104个肺腺癌组织中对抗素表达的免疫组合化学分析.
- 在498名肺癌患者和213名对照患者中,RETN多态的基因定型 (rs1862513,rs3745367).
- 统计分析包括后勤回归和元分析.
主要成果:
- 耐药性表达与转移和肺腺癌的整体存活率正相关.
- 在RETN多态和整体存活率,癌症风险或化疗反应之间没有发现显著的关联.
- RETN rs1862513多态性与严重的胃肠道毒性有关.
结论:
- 抵抗性表达与肺癌的进展和存活率有关.
- RETN多态性似乎没有影响肺癌风险或整体存活率.
- 在接受化疗的肺癌患者中,RETN rs1862513可能作为胃肠道毒性的预测生物标志物,需要进一步验证.
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
03:18Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K